Exponent CEO Corrigan sells $263k in stock
Exponent Inc. (NASDAQ:EXPO) CEO Catherine Corrigan sold 3,920 shares of company stock worth approximately $263,239 on February 17, 2026, after exercising options for 5,606 shares. This transaction followed Exponent's strong fourth-quarter 2025 earnings report, where the company surpassed analyst expectations in both revenue and earnings per share.
This Insider Has Just Sold Shares In Exponent
John Pye, an insider at Exponent, Inc. (NASDAQ:EXPO), recently sold US$304k worth of shares at an average price of US$75.97, reducing his holding by 14%. While the sale was significant, it occurred at a price higher than the current market value of US$66.79. The article highlights that no insider purchases were made over the last year, suggesting caution despite insiders owning 1.0% of the company.
Exponent: A Calm Business in a Nervous Market
Exponent is a unique professional services firm that provides expert analysis in cases of product failure, regulatory scrutiny, and litigation. The company is characterized by its capital-light business model, high operating margins, and consistent cash flow, driven by its intellectual capital rather than aggressive expansion. While it offers stable, predictable returns, its growth is naturally bounded by external events and its reputation-driven approach, making it more suited for investors seeking durability and measured compounding rather than rapid growth or speculative opportunities.
Envestnet Asset Management Inc. Has $28.10 Million Stock Position in Exponent, Inc. $EXPO
Envestnet Asset Management Inc. has reduced its stake in Exponent, Inc. by 4.8%, now holding 404,459 shares valued at $28.10 million. Despite this, institutional investors collectively own 92.37% of Exponent's stock, with new positions established by firms like Norges Bank and First Trust Advisors. Exponent recently exceeded quarterly earnings estimates, raised its dividend, and authorized a $100 million share buyback program.
Insider Selling: Exponent (NASDAQ:EXPO) VP Sells 4,000 Shares of Stock
Exponent (NASDAQ:EXPO) VP John Pye sold 4,000 shares of the company's stock on February 10th for $75.97 per share, reducing his position by 13.7% to 25,204 shares. The sale followed Exponent's strong Q4 earnings, where the company beat analyst estimates on both EPS and revenue. Exponent also raised its quarterly dividend and authorized a $100 million share buyback program.
Insider Sell: John Pye Sells 4,000 Shares of Exponent Inc (EXPO)
John Pye, Vice President of Global Offices & Innovation at Exponent Inc (EXPO), sold 4,000 shares of the company on February 10, 2026, bringing his total ownership to 25,204 shares. This transaction is part of a pattern of insider selling at Exponent Inc, with no insider buys in the past year and 12 insider sells. The stock is currently trading at $75.97, and GuruFocus analysis indicates it is modestly undervalued with a price-to-GF-Value ratio of 0.83.
The Top 5 Analyst Questions From Exponent's Q4 Earnings Call
Exponent (EXPO) surpassed Q4 expectations, driven by growth in both proactive and reactive consulting, particularly in AI-embedded consumer electronics and utility risk management. CEO Catherine Corrigan highlighted the company's strength in high-stakes environments where AI meets physics. Analysts primarily focused on the sustainability of consumer electronics rebound, 2026 margin and revenue growth, potential margin pressure from headcount increases, and the net impact of AI on their consulting business.
Exponent outlines high single-digit revenue growth and margin expansion targets for 2026 amid AI-driven demand
Exponent, a leading engineering and scientific consulting firm, has set ambitious financial targets for 2026, aiming for high single-digit revenue growth and operating margin expansion. The company anticipates strong demand across its service lines, particularly from AI-driven initiatives. Exponent's strategy involves disciplined capital allocation to support growth and shareholder returns.
Exponent (EXPO) Is Up 11.0% After Raising Dividend And Guiding For High-Single-Digit 2026 Growth - Has The Bull Case Changed?
Exponent (EXPO) recently reported strong Q4 2025 results, with increased sales, revenue, and an earnings beat. The company also announced a higher quarterly dividend of US$0.31 per share and projected high-single-digit revenue growth for 2026, driven by demand in AI, user research, and risk management. Despite a slight dip in full-year net income and elevated valuation multiples, this positive outlook has boosted sentiment and reinforced the company's investment narrative as a premium-priced, specialized consulting business.
Exponent (EXPO) Upgraded to Buy: Here's What You Should Know
Exponent (EXPO) has been upgraded to a Zacks Rank #2 (Buy), indicating a positive trend in its earnings estimates which often correlates with stock price movements. The Zacks Rank system, known for its accuracy, relies solely on a company's changing earnings outlook. This upgrade suggests an improvement in Exponent's underlying business and its potential for market-beating returns.
Exponent (NASDAQ:EXPO) Is Increasing Its Dividend To $0.31
Exponent, Inc. (NASDAQ:EXPO) has announced an increase in its quarterly dividend to $0.31 per share, representing a 3.3% rise from the previous year. This brings the dividend yield to 1.5%, which is consistent with the industry average. The company's dividend payments appear sustainable, supported by strong earnings coverage and a history of steady growth, with EPS expected to grow by 22% next year.
Exponent Inc. Stock Surges Amid Dividend Increase and Robust Earnings
Exponent Inc. (EXPO) has seen its stock surge by 13.71% following a dividend increase to $0.31 per share and robust Q4 earnings that surpassed estimates. The company reported revenue of $147.43 million against an estimate of $130.92 million and adjusted EPS of $0.49, exceeding the consensus of $0.47. JPMorgan initiated coverage with an Overweight rating and a $100 price target, highlighting a positive outlook driven by strong fundamentals and growth projections in key sectors.
Exponent (EXPO) Is Up 11.0% After Raising Dividend And Guiding For High-Single-Digit 2026 Growth - Has The Bull Case Changed?
Exponent (EXPO) recently reported strong fourth-quarter 2025 results, demonstrating sales and revenue growth and a modest increase in EPS. The company also announced an increased quarterly dividend to US$0.31 per share and projected high-single-digit revenue growth for 2026, driven by demand in AI, user research, and risk management services. This positive financial performance and outlook have boosted short-term investor sentiment, despite existing concerns about its premium valuation and slight dip in full-year net income.
Analysts Are Bullish on Top Industrial Goods Stocks: Rockwell Automation (ROK), Exponent (EXPO)
Analysts are maintaining bullish sentiments for Rockwell Automation (ROK) and Exponent (EXPO) in the Industrial Goods sector. Morgan Stanley maintained a Buy rating on Rockwell Automation with a $440.00 price target, while Truist Financial maintained a Buy rating on Exponent. Both companies have positive analyst consensus ratings.
Analysts Are Bullish on Top Industrial Goods Stocks: Exponent (EXPO), Advanced Drainage Systems (WMS)
This article highlights bullish sentiments from financial analysts regarding several industrial goods stocks. Specifically, it details Buy ratings and price targets for Exponent (EXPO) from William Blair and J.P. Morgan, Advanced Drainage Systems (WMS) from KeyBanc and TipRanks – xAI, and Carrier Global (CARR) from Barclays and TipRanks – Google. The analysts project significant upside potential for these companies based on their current price levels.
Exponent (EXPO) Stock Trades Up, Here Is Why
Shares of scientific consulting firm Exponent (EXPO) surged over 12% after the company reported strong fourth-quarter 2025 financial results, beating analyst estimates for revenue and earnings. A positive outlook for 2026, anticipating high single-digit net revenue growth and expanded margins, fueled investor confidence. The company also declared a quarterly cash dividend of $0.31 per share.
Exponent (EXPO) Q4 2025 Earnings Beat & 2026 Outlook Drive Stock Surge - News and Statistics
Exponent (NASDAQ:EXPO) saw its stock jump 12.3% after reporting strong Q4 2025 financial results that surpassed analyst expectations and providing a positive 2026 forecast. The scientific consulting firm announced quarterly revenue of $147.4 million, a 19.1% year-over-year increase, and earnings per share of $0.49, beating the $0.47 consensus. Despite the recent surge, the stock remains 12.5% below its 52-week high, and a $1,000 investment five years ago would now be valued at $869.87.
Exponent, Inc. (NASDAQ:EXPO) to Issue Dividend Increase - $0.31 Per Share
Exponent, Inc. (NASDAQ:EXPO) has announced a quarterly dividend increase to $0.31 per share, representing a 3.3% rise from its previous dividend. The business services provider has consistently increased its dividend for 12 years and maintains a payout ratio of 56.1%. Analysts project the company will continue to cover its annual dividend given expected future earnings per share.
Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO) reported a strong finish to 2025, with Q4 net revenues up 5% (low double digits adjusted for an extra week in 2024) and EPS of $0.49, exceeding expectations. The company highlights growth driven by proactive engagements in consumer electronics and risk management in utilities, as well as reactive services in failure analysis across various sectors, all significantly influenced by the increasing complexity of AI and advanced technologies. For 2026, Exponent anticipates high single-digit revenue growth and stable to improved EBITDA margins, emphasizing increased demand for its multidisciplinary expertise in navigating novel technologies and critical systems.
Exponent outlines high single-digit revenue growth and margin expansion targets for 2026 amid AI-driven demand
Exponent (NASDAQ:EXPO) has set ambitious financial targets for 2026, aiming for high single-digit annual revenue growth and a 300 basis point expansion in its adjusted EBITDA margin compared to 2023. These goals are supported by strong demand drivers, particularly in the artificial intelligence sector, and strategic investments in critical talent and technology. The company also anticipates capital expenditures of 2-3% of annual revenue and a strong free cash flow conversion rate of 90-100% of net income.
Exponent, Inc. Reports Strong Q4 2025 Earnings with AI-Driven Growth
Exponent, Inc. reported strong Q4 2025 earnings with an 8% increase in revenues to $147.4 million, net income of $24.8 million, and diluted EPS of $0.49, driven by demand in user research and risk management. The company projects high single-digit revenue growth and consistent EBITDA margins for Q1 and full-year 2026, supported by a diversified client base and robust cash flow. Wall Street analysts maintain a "Moderate Buy" rating, with an average 1-year price target of $85.50, citing Exponent's strong rebound potential and leadership in science and engineering consulting.
Exponent Inc (NASDAQ:EXPO) Reports Q4 Earnings Beat and Provides 2026 Outlook
Exponent Inc (NASDAQ:EXPO) reported a Q4 2025 earnings beat with diluted EPS of $0.49, exceeding analyst estimates, although revenues before reimbursements fell short at $129.4 million. The company provided optimistic guidance for fiscal year 2026, expecting high-single-digit revenue growth and an EBITDA margin between 27.6% and 28.1%. Exponent also increased its quarterly cash dividend to $0.31 per share, demonstrating confidence in future performance and continued commitment to shareholder returns.
Exponent (NASDAQ:EXPO) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Exponent (NASDAQ:EXPO) announced its quarterly earnings, reporting an EPS of $0.49, surpassing analyst expectations by $0.02. The company also disclosed $147.43 million in revenue, exceeding estimates, and highlighted strong cash reserves alongside significant share buybacks. Management projects continued growth for FY26, anticipating high-single-digit net revenue increase and EBITDA margins between 27.6% and 28.1%, with AI identified as a key growth driver despite some near-term margin pressures.
Exponent's (NASDAQ:EXPO) Q4 CY2025: Strong Sales
Exponent (NASDAQ:EXPO) reported strong Q4 CY2025 results, with revenue of $147.4 million significantly exceeding analyst estimates by 15.1%, and sales up 19.1% year-on-year. The company's GAAP profit of $0.49 per share also beat consensus estimates by 3.7%. Despite a decrease in operating margin, Exponent's President and CEO, Dr. Catherine Corrigan, highlighted the strength and resilience of their portfolio.
Exponent: Q4 Earnings Snapshot
Exponent Inc. (EXPO) reported a fourth-quarter profit of $24.8 million, or 49 cents per share, surpassing Wall Street expectations of 47 cents per share. The engineering and scientific consulting company also exceeded revenue forecasts, posting $147.4 million in revenue, with adjusted revenue of $129.4 million, against an estimated $128.3 million. For the full year, Exponent recorded a profit of $106 million on revenue of $536.8 million.
Earnings call transcript: Exponent Q4 2025 earnings beat expectations
Exponent Inc. (EXPO) reported strong Q4 2025 earnings, surpassing analyst expectations with an 8% year-over-year revenue increase to $147.4 million and an EPS of $0.49. The company highlighted growth driven by AI-powered product development and health-related technology consulting. For 2026, Exponent anticipates high single-digit net revenue growth and stable EBITDA margins, fueled by continued demand in critical and complex technological systems.
Exponent: Q4 Financial Results Overview
Exponent Inc., an engineering and scientific consulting firm, exceeded expectations in its fourth quarter, reporting a net profit of $24.8 million, or 49 cents per share, which was higher than analyst estimates. The company generated $147.4 million in revenue, with adjusted revenue of $129.4 million also surpassing projections. For the full fiscal year, Exponent recorded a total profit of $106 million on $536.8 million in annual revenue.
Engineering firm Exponent nudges quarterly dividend up to $0.31
Exponent Inc. (Nasdaq: EXPO) has announced an increase in its quarterly cash dividend from $0.30 to $0.31 per share of common stock for Q1 2026. The dividend is payable on March 20, 2026, to stockholders of record as of March 6, 2026. This increase reflects the company's commitment to returning capital to shareholders and confidence in its business, driven by strong market drivers and scientific capabilities.
Exponent (EXPO) Q4 Earnings: What To Expect
Exponent (EXPO) is scheduled to report its Q4 earnings this Thursday after market hours. Analysts predict a 3.5% year-on-year revenue growth to $128.1 million and adjusted earnings of $0.47 per share. The company has a mixed history of meeting Wall Street's revenue estimates.
Retirement Systems of Alabama Increases Stock Position in Exponent, Inc. $EXPO
Retirement Systems of Alabama significantly increased its stake in Exponent, Inc. ($EXPO) by 46.2% in Q3, now owning 90,658 shares valued at approximately $6.30 million. This move is part of broader institutional interest, with such investors holding 92.37% of the company's stock. The article highlights positive analyst sentiment, strong Q3 earnings beats, and a $100 million share buyback authorization, indicating a bullish outlook for Exponent.
Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth
Exponent (EXPO) is projected to announce a year-over-year increase in earnings and higher revenues for the quarter ended December 2025, with an earnings report anticipated on February 5. The company's Most Accurate Estimate for EPS is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.53% and a Zacks Rank of #3, suggesting a strong likelihood of beating consensus EPS estimates. This positive outlook is further supported by Exponent's history of consistently beating EPS estimates over the past four quarters.
Exponent (EXPO) Projected to Announce Quarterly Earnings on Thursday
Exponent (NASDAQ:EXPO) is scheduled to announce its Q4 2025 earnings after market close on Thursday, February 5th, with analysts projecting $0.47 EPS and $128.48 million in revenue. The company previously beat estimates in Q3 2025, reporting $0.55 EPS and $147.12 million in revenue, and its board recently authorized a $100 million share buyback. Institutional investors hold approximately 92% of the company's stock, which currently has a "Moderate Buy" consensus rating and a target price of $90.50 from analysts.
Will Exponent (EXPO) Beat Estimates Again in Its Next Earnings Report?
Exponent (EXPO), a Zacks Consulting Services industry company, has a strong history of beating earnings estimates, surprising by an average of 9.17% in the last two quarters. With a positive Zacks Earnings ESP of +1.41% and a Zacks Rank #3 (Hold), the company is well-positioned for another potential earnings beat, with its next report expected on February 5, 2026. This combination suggests a high probability of exceeding analyst expectations.
Y Intercept Hong Kong Ltd Sells 15,988 Shares of Exponent, Inc. $EXPO
Y Intercept Hong Kong Ltd significantly reduced its stake in Exponent, Inc. by 28.3% in Q3, selling 15,988 shares and retaining 40,599 shares valued at $2.82 million. Concurrently, CEO Catherine Corrigan sold 4,900 shares for over $344,000, contributing to a total of $693,648 in insider sales over the last 90 days. Despite these sales, analysts maintain a "Moderate Buy" rating for Exponent with a consensus price target of $90.50, following strong earnings, a declared dividend, and a $100 million share buyback authorization.
Analysts’ Top Industrial Goods Picks: Xylem (XYL), Exponent (EXPO)
Two analysts have issued bullish sentiments on Industrial Goods sector stocks Xylem (XYL) and Exponent (EXPO). Brian Drab from William Blair maintained a Buy rating for Xylem, citing its strong performance near its 52-week high, while Tomohiko Sano from J.P. Morgan initiated coverage on Exponent with a Buy rating and a $100.00 price target, noting the company's strong analyst consensus for a Strong Buy.
Why Exponent (EXPO) Stock Is Trading Up Today
Shares of Exponent (EXPO) rose 2.3% after JPMorgan initiated coverage with an 'Overweight' rating and a $100 price target, citing the company's leadership in science and engineering consulting and strong rebound potential. The investment bank projected a 35% upside potential and accelerated revenue growth for Exponent in 2026. Despite a previous dip related to a weak U.S. jobs report, the stock is up 8% year-to-date, though still below its 52-week high.
JPMorgan Chase & Co. Begins Coverage on Exponent (NASDAQ:EXPO)
JPMorgan Chase & Co. has initiated coverage on Exponent (NASDAQ:EXPO) with an "Overweight" rating and a $100 price target, suggesting a potential upside of over 34%. This positive outlook follows Exponent's strong recent quarterly performance, exceeding revenue and EPS estimates, alongside a board-approved $100 million share repurchase program. The stock's current average analyst rating is "Moderate Buy" with an average price target of $90.50.
Why Exponent (EXPO) Stock Is Trading Up Today
Exponent (EXPO) shares rose 2.3% after JPMorgan initiated coverage with an 'Overweight' rating and a $100 price target, citing the company's leadership in science and engineering consulting and expected revenue growth acceleration. JPMorgan projects a 35% upside potential for the stock. Despite this positive movement, the stock is still trading 19.1% below its 52-week high from January 2025.
JPMorgan Initiates Coverage on Exponent With Overweight Rating, $100 Price Target
JPMorgan has initiated coverage on Exponent Inc. (EXPO) with an Overweight rating and a price target of $100. This new coverage suggests a positive outlook for the science and engineering consulting firm. The announcement was made on January 26, 2026.
JPMorgan initiates Exponent stock with Overweight rating, $100 target
JPMorgan initiated coverage on Exponent (NASDAQ:EXPO) with an Overweight rating and a $100 price target, representing a significant upside. The investment bank anticipates accelerated revenue growth, margin expansion, and double-digit EPS growth for the science and engineering consulting leader. This positive outlook follows strong Q3 2025 results for Exponent, which surpassed earnings and revenue forecasts, leading to analyst upgrades and increased price targets from other firms as well.
Resona Asset Management Co. Ltd. Buys 109,160 Shares of Exponent, Inc. $EXPO
Resona Asset Management Co. Ltd. significantly increased its stake in Exponent, Inc. by 18.3% in the third quarter, acquiring 109,160 additional shares and now owning 1.40% of the company, valued at approximately $48.98 million. This increase follows Exponent's strong Q3 performance, beating EPS and revenue estimates, declaring a quarterly dividend, and approving a $100 million share buyback program. Institutional investors collectively own 92.37% of Exponent, which analysts currently rate as a "Hold" with an average price target of $81.00.
What Exponent (EXPO)'s Insider Stock Moves After a Strong Q3 Means For Shareholders
Exponent's President and CEO, Catherine Corrigan, sold shares while exercising options shortly after the company reported strong Q3 results that beat expectations. This activity, combined with positive analyst commentary and the company's performance, is influencing investor perception. While the stock trades at a premium, the strong quarter has raised expectations for future performance, with little room for disappointment.
Vest Financial LLC Grows Stock Position in Exponent, Inc. $EXPO
Vest Financial LLC significantly increased its stake in Exponent, Inc. by 157.3% in Q3, now holding 36,813 shares valued at approximately $2.56 million. This comes as Exponent reported strong Q3 earnings, exceeding analyst expectations, and authorized a $100 million share buyback program. Despite insider selling activity, the company maintains a "Hold" consensus rating from analysts with an $81 target price.
Corrigan, Exponent Inc president, sells $120,593 in EXPO stock
Catherine Corrigan, President and CEO of Exponent Inc, sold 1,663 shares of EXPO common stock for $120,593 on January 15, 2026, while also exercising options to acquire 2,380 shares for $69,139. The company has a strong financial health score, has raised its dividend for 13 consecutive years, and holds more cash than debt. This comes after Exponent Inc. recently reported strong third-quarter results and received positive analyst upgrades.
Corrigan, Exponent Inc president, sells $120,593 in EXPO stock
Catherine Corrigan, President and CEO of Exponent Inc (NASDAQ:EXPO), sold 1,663 shares of company stock for $120,593, while also exercising options to acquire 2,380 shares. This transaction occurred near InvestingPro’s Fair Value, with the company demonstrating strong financial health, including 13 consecutive years of dividend raises and more cash than debt. Exponent Inc. has recently reported impressive third-quarter results, surpassing earnings and revenue expectations, leading to analyst upgrades and raised price targets.
Catherine Corrigan Sells 1,663 Shares of Exponent (NASDAQ:EXPO) Stock
Exponent CEO Catherine Corrigan sold 1,663 shares of the company's stock on January 15th for over $120,000, reducing her stake to 92,723 shares. This sale follows previous transactions in December and November. The company recently reported strong quarterly earnings, exceeding analyst expectations, and announced a quarterly dividend and a $100 million share buyback program.
Exponent to Announce Fourth Quarter and Fiscal Year 2025 Results and Host Quarterly Conference Call on February 5, 2026
Exponent, Inc. (Nasdaq: EXPO) announced that it will report its Fourth Quarter and fiscal year 2025 financial results on Thursday, February 5, 2026, after market close. The company's CEO, Dr. Catherine Corrigan, and CFO, Richard Schlenker, will host a conference call and webcast to discuss the results at 4:30 p.m. ET on the same day. The webcast will be accessible through the investor relations section of Exponent's website.
Exponent to Announce Fourth Quarter and Fiscal Year 2025 Results and Host Quarterly Conference Call on February 5, 2026
Exponent, Inc. (Nasdaq: EXPO) announced it will report its Fourth Quarter and fiscal year 2025 financial results on February 5, 2026, after the market closes. Following the release, CEO Catherine Corrigan and CFO Richard Schlenker will host a conference call and webcast to discuss the results. The event will take place at 4:30 p.m. ET, with details provided for live access and webcast replay.
Exponent to Announce Fourth Quarter and Fiscal Year 2025 Results and Host Quarterly Conference Call on February 5, 2026
Exponent, Inc. (Nasdaq: EXPO) announced it will report its Fourth Quarter and Fiscal Year 2025 financial results on February 5, 2026, after market close. Following the announcement, CEO Catherine Corrigan and CFO Richard Schlenker will host a conference call and webcast to discuss the results and the company's business. The event will be accessible via live call and webcast through Exponent's investor relations website.
What Exponent, Inc.'s (NASDAQ:EXPO) P/E Is Not Telling You
Exponent, Inc. (NASDAQ:EXPO) has a high price-to-earnings (P/E) ratio of 34.9x, which is significantly above the market average in the United States. However, the company's recent earnings growth has been negative, and future growth forecasts from analysts are lower than the broader market. This suggests that the current high P/E might be unjustified and could pose a risk to investors if sentiment shifts to align with the company's growth outlook.
